Navigation Links
Inaugural Global Awareness Event Shines Spotlight On Plasma Donors And Rare Diseases
Date:9/3/2013

ANNAPOLIS, Md., Sept. 3, 2013 /PRNewswire/ -- The first ever International Plasma Awareness Week (IPAW) will be celebrated October 13-20. A joint initiative of the Plasma Protein Therapeutics Association (PPTA) and its member companies, IPAW is designed to:

  • Raise global awareness about source plasma collection
  • Recognize the contributions of plasma donors in  saving and improving lives
  • Increase understanding about lifesaving plasma protein therapies and rare diseases

(Logo: http://photos.prnewswire.com/prnh/20130903/PH72000LOGO)

Member companies are planning a variety of activities including: donor appreciation events, as well as, open houses for patients, government officials and the media at over 450 plasma collection facilities in Europe and the U.S. In addition, patient organizations representing individuals with rare diseases have pledged support for the event.

"People throughout the world rely on plasma protein therapies which are developed through the generosity and commitment of plasma donors. PPTA is proud of the contributions we and our member companies make to saving and improving lives and is delighted to sponsor an annual event that draws attention to rare diseases," said Joshua Penrod, PPTA, Vice President, Source

Plasma, a biological material that cannot be manufactured, is used to create lifesaving therapies that come solely from committed plasma donors in the U.S., Canada, Germany, Austria and the Czech Republic. In addition to meeting regulatory requirements, the majority of these centers have achieved International Quality Plasma Program (IQPP) certification.  PPTA's voluntary standards program provides global leadership for the industry's goal of continuous improvement with a focus on safety and quality from the donor to the patient.  

Plasma protein therapies, which include plasma-derived therapies and recombinant analogs are used to treat chronic, life-threatening diseases including bleeding disorders, primary immune deficiencies, alpha-1 antitrypsin deficiency and certain rare neurological disorders. In addition, these therapies are used in emergency and surgical medicine.

As PPTA celebrates the generosity of plasma donors and works to raise awareness for the rare diseases during International Plasma Awareness Week, we encourage everyone to thank donors who help to ensure a higher quality of life for patients around the world.

Learn more about plasma protein therapies, the diseases they treat and Donating Plasma.

About PPTA
PPTA represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. PPTA member companies produce approximately 80% of the therapies in the U.S. and 60% of those manufactured in Europe. PPTA works globally to advocate for access to and affordability of therapies; engage in constructive dialogue with regulatory authorities and collaborate with patient organizations. PPTA also administers standards and programs that help ensure the quality and safety of plasma, manufacturing, donors and patients.


'/>"/>
SOURCE Plasma Protein Therapeutics Association (PPTA)
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Inaugural Meeting of the FirstMark Scientific Board of Advisors
2. Maine Center for Creativity Selects Glenn Close and David Shaw to Receive Inaugural Maine Creative Industry Award
3. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
4. BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference
5. USC Center For Applied Molecular Medicine To Honor Sumner Redstone And Murray Gell-Mann, Ph.D. At The Inaugural REBELS WITH A CAUSE Gala
6. Bayer CropScience Hosts Inaugural Vegetable Future Forum in Monheim
7. Genuine Bio-Fuel Inc. Notes Sustainable Energy Gets A Much Needed Boost from the President Obama During 2013 Inaugural Address
8. Nominations Open for the Inaugural Harrington Prize for Innovation in Medicine
9. Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award
10. Bayer CropScience Sponsors U.S. Delegates at Inaugural Global Youth Ag Summit
11. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
(Date:3/22/2017)... - FACIT announced a seed stage investment in ... created by FACIT focused on developing a portfolio ... non-dilutive capital, achieves a targeted $3.0M financing for ... to accelerate the nomination of a candidate drug ... a strategic partnership for clinical trials in patients ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation is ... the desired increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, there ... therapeutic antibodies. , To meet this demand, the team at SCIEX has ...
(Date:3/22/2017)... and CARDIFF, UK (PRWEB) , ... March 21, 2017 , ... ... flow and tissue oxygenation, is being explored as a way to track the brain’s ... study on tonic pain activation by cold pressor test ,” published today in the ...
Breaking Biology Technology:
(Date:3/6/2017)... 2017 Mintigo , the leader ... Predictive Sales Coach TM , its new artificial ... into Salesforce. This unique AI application will allow ... with deep knowledge of their customers and prospects ... Predictive Sales Coach extends Mintigo,s existing customer success ...
(Date:3/1/2017)... Mass. , March 1, 2017  Aware, Inc. ... services, announced that Richard P. Moberg has ... and co-President and Chief Financial Officer and Treasurer of ... continue to serve as a member of the Board ... Russell , Aware,s co-Chief Executive Officer and co-President, General ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
Breaking Biology News(10 mins):